logo

For the Inventor, By the Inventor

Somerville, NJ, United States of America

Nicholas J Hrib

This inventor holds 42 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Hoechst Roussel Pharmaceuticals, Hoechst Marion Roussel, Aventis Pharmaceuticals Inc.. Active years: 1988-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas J Hrib. Retrieved from https://idiyas.com/inventor/nicholas-j-hrib

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 42

% Patents Active = 90.5


Average Co-Inventor Count = 1.8

ph-index = 6

Forward Citations = 207(Granted Patents)


Location History:

  • Somerville, NJ (US) (1988 - 2001)
  • Hillsborough, NJ (US) (2006 - 2009)

Company Filing History:

goldMedal28 out of 539 
 
Hoechst Roussel Pharmaceuticals
 patents
silverMedal5 out of 236 
 
Hoechst Marion Roussel
 patents
bronzeMedal4 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
4. 1 out of 1 
 
Aventis Hoklings Inc.
 patent
5. 1 out of 1 
 
Frommer Lawrence & Huag LLP
 patent
6. 1 out of 1 
 
Heochst-Roussel Pharmaceuticals, Inc.
 patent
7. 1 out of 1 
 
Hoeschst-Roussel Incorporated
 patent
8. 1 out of 834,708 
Other
 patents

Years Active: 1988-2009

Loading Chart...
Loading Chart...
Areas of Expertise:
Piperazine Derivatives
Oxelabdanes
Forskolin Synthesis
Thiazolidinones
Antipsychotic Agents
Alkoxycarbonylalkylphospholipids
Indole Derivatives
Heteroarenylpiperazines
Carboxamides
Anxiety Treatment
Chemical Synthesis
Pharmaceutical Compounds
42 patents (USPTO):Explore Patents
1. 7511046 - [object Object] (2009-03-31),
2. 7253165 - [object Object] (2007-08-07),
3. 7169925 - Indole derivatives as interleukin-4 gene expression inhibitors (2007-01-30),
4. 7125903 - [object Object] (2006-10-24),
5. 6284775 - 3-[4-(1-substituted-4-piperazinyl)butyl]-4-thiazolidinone and related compounds (2001-09-04),
6. 5880121 - 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof (1999-03-09),
7. 5869480 - Substituted-4-amino-3-pyridonols (1999-02-09),
8. 5866565 - Substituted-4-amino-3-pyridinols (1999-02-02),
9. 5821239 - Substituted-4-amino-3-pyridinols (1998-10-13),
10. 5801186 - 3-�4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related (1998-09-01),
11. 5801176 - Substituted benzothienylpiperazines and their use (1998-09-01),
12. 5440048 - 1-piperazinyl-2-butenes and -2-butynes (1995-08-08),
13. 5371087 - 3-<4-substituted-4-piperazinyl)buty]-4-thiazolidinone and related (1994-12-06),
14. 5334715 - 1-piperazinyl-2-butenes and -2-butynes (1994-08-02),
15. 5272148 - Heteroarenylpiperazines (1993-12-21),

Title: The Innovative Journey of Nicholas J Hrib

Introduction:

Nicholas J Hrib, a talented inventor hailing from Somerville, NJ, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents:

Nicholas J Hrib holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing new solutions to complex problems.

Career Highlights:

Throughout his illustrious career, Nicholas J Hrib has consistently pushed the boundaries of innovation, earning recognition for his cutting-edge inventions that have had a profound impact on the industry.

Collaborations:

Nicholas J Hrib has collaborated with leading tech companies and research institutions, leveraging his expertise to drive collaborative projects that have resulted in groundbreaking innovations.

Conclusion:

Nicholas J Hrib's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors, inspiring the next generation of innovators to dream big and think outside the box.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…